Lichun Zhao | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Dr. Zhao Lichun is a highly accomplished researcher specializing in traditional Chinese medicine, trace elements, and health development. Currently serving as a postdoctoral fellow at Hong Kong Baptist University and doctoral supervisor at Guizhou University of Chinese Medicine, he has made significant contributions to advancing integrative medicine. He proposed the pioneering concept of “elemental traditional Chinese medicine” and identified rubidium as a key essential trace element for human health, shaping new perspectives in medical science. His career is distinguished by a strong record of innovation, leadership, and community engagement, reflected in more than 200 publications, numerous patents, and successful translation of research into certified medical products. Beyond his scientific work, Dr. Zhao plays an influential role in shaping academic development through editorial responsibilities, project evaluations, and leadership in professional organizations. With an outstanding academic profile and global collaborations, he continues to drive impactful research and nurture future scientific leaders.

Professional Profile 

Scopus Profile

Education

Dr. Zhao Lichun holds a Ph.D. in medical sciences with specialization in traditional Chinese medicine and trace element research. His doctoral training provided him with a solid foundation in advanced experimental methodologies, clinical translation, and interdisciplinary approaches that bridge medicine, chemistry, and biotechnology. Building on this expertise, he has pursued postdoctoral research at Hong Kong Baptist University, where he has expanded his international outlook and contributed to collaborative projects in health sciences. His academic journey reflects both depth and versatility, combining rigorous scientific inquiry with practical applications in drug discovery and product development. In addition to formal degrees, Dr. Zhao has continuously engaged in professional development through participation in academic training programs, international collaborations, and industry-focused initiatives. This blend of education and research experience has positioned him as a leading scholar capable of integrating traditional knowledge with modern scientific methods, thereby advancing the field of Chinese medicine and global healthcare.

Experience

Dr. Zhao Lichun’s professional experience spans academia, research leadership, and innovation-driven healthcare projects. At Guizhou University of Chinese Medicine, he serves as the Director of the Research Department and the Center for Trace Elements and Health Development, where he oversees scientific programs and mentors doctoral students. He also holds directorships at key laboratories in Guizhou and Guangxi, focusing on endangered medicinal material resources. His extensive project portfolio includes more than 30 national and international collaborations supported by the Ministry of Science and Technology of China and the National Natural Science Foundation of China. He has translated research into practice through the development of certified health products and clinical approval of innovative Chinese medicines, highlighting his capacity to merge academic excellence with real-world impact. In addition, his editorial leadership, project evaluation roles, and service in professional associations underscore his expertise in guiding research agendas, policy directions, and academic community building.

Research Interest

Dr. Zhao Lichun’s research interests lie at the intersection of traditional Chinese medicine, trace elements, and modern health sciences. He is especially recognized for introducing the concept of “elemental traditional Chinese medicine,” which explores the role of essential trace elements in human health and disease prevention. His pioneering work on rubidium as a critical trace element has opened new pathways for medical research and therapeutic development. Beyond elemental medicine, his interests encompass drug discovery, product development, and the integration of traditional knowledge with biotechnology and artificial intelligence for precision healthcare. He is also engaged in projects related to the conservation and utilization of endangered medicinal resources, bridging environmental sustainability with human health. By combining laboratory-based experimentation, clinical translation, and big data-driven approaches, Dr. Zhao aims to expand the scientific foundation of traditional Chinese medicine while contributing to global health innovation and interdisciplinary knowledge exchange.

Awards and Honors

Dr. Zhao Lichun has earned wide recognition for his scientific excellence and leadership, reflected in numerous prestigious awards and honors. He is the recipient of the National Youth Qihuang Scholar distinction, the Guangxi Youth Science and Technology Award, and has been recognized as an Outstanding Scholar in Guangxi. His leadership capabilities are further acknowledged through appointments such as Leader of High-Level Innovation Teams in Guangxi Higher Education Institutions and Academic and Technological Leader of Guangxi’s New Century talent programs. Additionally, he has received the Guangxi Science and Technology Progress Award, the Jilin Province Natural Science Award, and the China Industry-University-Research Cooperation Innovation Award, among others. Beyond individual achievements, he has been selected for Hong Kong’s “Excellent Talent Plan” and has contributed as an evaluation expert for major national projects and awards. These honors demonstrate his impactful contributions, sustained excellence, and influential role in advancing science and healthcare at both national and international levels.

Research Skills

Dr. Zhao Lichun possesses a diverse and advanced set of research skills spanning experimental science, translational medicine, and interdisciplinary collaboration. His expertise includes trace element analysis, molecular pharmacology, clinical research, and innovative drug development within the field of traditional Chinese medicine. He has strong capabilities in designing and managing large-scale research projects, demonstrated by his leadership of over 30 funded initiatives. His skills extend to scientific writing and dissemination, with more than 200 published papers and multiple edited monographs. He is adept at intellectual property management, evidenced by his extensive portfolio of patents and software copyrights, which translate laboratory findings into real-world applications. In addition, Dr. Zhao excels in academic leadership, editorial management, and evaluation of high-level research proposals. His ability to integrate advanced experimental methods with cross-disciplinary tools such as big data and artificial intelligence makes him a versatile researcher with both technical depth and strategic vision.

Publications Top Notes

Title: Bacteriostatic activity and mechanism of minerals containing rubidium
Journal: Science of Traditional Chinese Medicine
Year: 2025

Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
Journal: Phytomedicine
Year: 2025
Citations: 3

Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
Year: 2025
Citations: 13

Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
Journal: ACS Applied Materials & Interfaces
Year: 2025

Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
Journal: Biomedicine & Pharmacotherapy
Year: 2024
Citations: 22

Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
Year: 2025

Conclusion

Dr. Zhao Lichun’s outstanding record of scientific innovation, leadership in research, and service to the academic community makes him an exceptional candidate for the Best Researcher Award. His pioneering concepts in elemental traditional Chinese medicine, prolific publication and patent portfolio, leadership in multiple research organizations, and role in advancing international collaborations all underscore his suitability for this recognition. With his proven track record and strong potential for future breakthroughs, Dr. Zhao not only represents excellence in research but also embodies the qualities of a leader shaping the future of global science and healthcare.

Zhendong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Global Scholar Awards

Mr. Zhendong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Phd student at University of Cologne, Germany

Mr. Zhendong Chen is a dedicated and accomplished researcher specializing in clinical pharmacology, pharmacokinetics, and pharmacometrics, with extensive experience in both academic and industry settings. Currently pursuing his PhD at the University of Cologne under the supervision of Professor Uwe Fuhr, Mr. Chen has contributed significantly to the development of population pharmacokinetic models, innovative joint modeling approaches, and advanced data analysis techniques. His research spans drug metabolism, renal function assessment, and therapeutic drug monitoring, demonstrating his versatility and technical expertise. With several peer-reviewed publications in respected journals, Mr. Chen has established a strong scientific presence, contributing valuable insights to drug development and personalized medicine. His collaborative work with institutions like Johnson & Johnson further highlights his ability to translate complex data into clinically relevant solutions. With his strong analytical skills, international experience, and commitment to advancing pharmacological science, Mr. Chen is a promising and highly capable researcher in his field.

Professional Profile 

  • Google Scholar
  • Scopus Profile
  • ORCID Profile

Education

Mr. Zhendong Chen has built a strong academic foundation through comprehensive education and specialized training in pharmacy, drug metabolism, and clinical pharmacology. He earned his Bachelor’s degree in Pharmacy from Sichuan University’s prestigious West China School of Pharmacy, where he developed a solid understanding of pharmaceutical sciences. Following this, he pursued a Master’s degree at the Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, under the supervision of Professor Dafang Zhong, focusing on drug metabolism and pharmacokinetics. During his time at SIMM, he gained valuable experience in both non-clinical and clinical pharmacokinetic studies, refining his expertise in analytical techniques and pharmacokinetic modeling. Currently, Mr. Chen is pursuing his PhD at the University of Cologne, Germany, under the guidance of Professor Uwe Fuhr. His doctoral research centers on clinical pharmacology and pharmacometrics, emphasizing population pharmacokinetics and innovative modeling strategies, further solidifying his academic and research credentials.

Professional Experience

Mr. Zhendong Chen has accumulated extensive professional experience across academic institutions, research institutes, and the pharmaceutical industry, with a focus on clinical pharmacology, pharmacokinetics, and pharmacometrics. Currently a PhD researcher at the University of Cologne, he is actively involved in developing innovative pharmacometric models to assess renal function, drug disposition, and pharmacogenetic influences. His work spans population pharmacokinetics, joint modeling strategies, and therapeutic drug monitoring in complex clinical settings, including cerebrospinal fluid drug penetration in critically ill patients. Prior to his PhD, Mr. Chen contributed to multiple non-clinical and clinical pharmacokinetic studies at the Shanghai Institute of Materia Medica, where he honed his expertise in bioanalysis and drug metabolism. His ongoing collaboration with Johnson & Johnson further enhances his experience in applying pharmacometric techniques to drug development, including exposure-response modeling and longitudinal data analysis. His broad professional background reflects strong analytical skills, multidisciplinary collaboration, and a commitment to advancing drug research and development.

Research Interest

Mr. Zhendong Chen’s research interests lie at the intersection of clinical pharmacology, pharmacometrics, and drug metabolism, with a particular focus on improving drug development and personalized medicine through advanced modeling techniques. He is passionate about developing population pharmacokinetic (popPK) and pharmacodynamic (PD) models to better understand the factors influencing drug absorption, distribution, metabolism, and excretion in diverse patient populations. His work also explores the impact of genetic polymorphisms, renal and hepatic function, and disease states on drug pharmacokinetics and pharmacodynamics, contributing to precision dosing strategies. Additionally, Mr. Chen is interested in joint modeling approaches, combining biomarker data with pharmacokinetic and clinical outcome data to enhance drug efficacy and safety predictions. His current work extends to therapeutic drug monitoring, drug penetration into cerebrospinal fluid, and the evaluation of novel methods for assessing renal function using pharmacometric tools, showcasing his dedication to advancing clinically relevant, data-driven drug research.

Award and Honor

Mr. Zhendong Chen has demonstrated exceptional academic and research excellence, earning several awards and honors throughout his educational and professional journey. During his undergraduate and graduate studies, he consistently achieved top rankings in his class, reflecting his strong academic performance and dedication to pharmaceutical sciences. His research contributions in clinical pharmacology, pharmacokinetics, and pharmacometrics have also been recognized through conference presentations and peer-reviewed publications in high-impact journals. In recognition of his outstanding research potential, Mr. Chen was selected for a prestigious research collaboration with Johnson & Johnson, where he applies advanced modeling techniques to drug development projects. Additionally, his collaborative work on innovative pharmacometric modeling strategies has been highlighted in international research forums, further cementing his reputation as a promising young researcher. Through his strong scientific output, collaborative spirit, and consistent commitment to excellence, Mr. Chen continues to build a distinguished profile in the global pharmaceutical research community.

Research skill

Mr. Zhendong Chen possesses a diverse and advanced set of research skills that span across clinical pharmacology, pharmacokinetics, pharmacometrics, and drug metabolism. He is highly proficient in population pharmacokinetic (popPK) and pharmacodynamic (PD) modeling, using software such as NONMEM for model development, covariate analysis, and model diagnostics. His expertise also extends to data processing and visualization using R, including programming custom scripts for data handling, analysis, and graphical presentation. Mr. Chen has hands-on experience with non-compartmental analysis (NCA), bioanalytical method development, and therapeutic drug monitoring, particularly in complex clinical scenarios such as cerebrospinal fluid drug penetration. His skills further include applying semi-mechanistic modeling approaches to integrate pharmacogenetics, disease progression, and organ function assessments into predictive models. With strong analytical thinking, problem-solving abilities, and interdisciplinary collaboration experience, Mr. Chen is adept at translating complex pharmacokinetic data into meaningful insights that guide dose optimization and personalized medicine strategies.

Conclusion

Zhendong Chen is a very strong candidate for a Best Researcher Award, particularly in the field of pharmacokinetics, pharmacometrics, and clinical pharmacology. His consistent publication output, diverse international research experience, technical expertise, and innovative projects make him highly competitive.